Case guide
The FDA dental alert covers Suboxone and generic drugs that dissolve in the mouth. Keep product records and ask what they mean for care or a claim.
Updated Oct 4, 202610 sources
See If You Qualify
Free · No obligation · About 2 minutes
Updated Oct 4, 202610 sources
This may apply to you if
These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.
Mahyar Etminan · Faculty of Medicine, University of British Columbia · Lead author of the dental claims-database study
Finding: The study recorded more dental problems among users of medicine held under the tongue than in its comparison groups.
Etminan and colleagues: dental disease cohort, JAMA 2022 (opens in a new tab) · Dec 13, 2022 · Checked Oct 3, 2026
University of British Columbia · JAMA · 2022
Read the source: Association Between Sublingual Buprenorphine-Naloxone Exposure and Dental Disease (opens in a new tab) · Checked Oct 3, 2026
The process
You answer a few questions
About two minutes. Nothing is sent until you agree on the last step and press submit.
A lawyer looks at it
A lawyer at the firm reads your answers and checks them against the current case criteria.
The firm decides and gets in touch
If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.
Yes, FDA’s dental warning includes generic drugs that dissolve in the mouth. It also covers Suboxone.
The route matters: the alert concerns tablets and films under the tongue or inside the cheek. Keep the full prescription name and packaging you have. A generic label is not a reason to ignore a dental concern, and a brand name alone does not identify every product detail.
Ask the pharmacy for your dispensing history. Keep the product name, dates and maker details shown in the record.
List any switches during treatment and which pharmacy filled each prescription. Do not assume all fills came from the same maker or had the same leaflet. Ask what older records remain available and identify gaps rather than relying on what a current box looks like.
It compares under-tongue treatment with two other treatment groups. It is not a legal test of each brand or generic maker.
More dental diagnoses were recorded in the under-tongue group, but hygiene information was missing and other factors could affect the finding. The study cannot settle what caused your own injury. A care assessment and a review of the maker’s legal duties need your own history.
Do not make a switch or suddenly stop treatment on your own. Speak with your prescriber and dentist about the warning.
FDA says the medicine’s benefits outweigh the risks. It advises a dental care plan and patient steps after the dose dissolves. Discuss those steps and any concern about the product with your providers; a claim guide cannot choose a treatment for you.
Ask a lawyer to check the product, maker and law. The FDA warning does not mean every generic user has the same legal claim.
The Suboxone court page describes film claims and alleged warning problems. Give a lawyer the pharmacy record before assuming the federal case includes you. Ask what parties and claims fit, whether any time limit needs urgent action and what evidence is missing.
Ask who will handle your product-specific review and what work is included. Get the fees and expense terms in writing.
A success-based fee is an agreed share of money recovered, while expenses may be charged separately and may remain due after a loss. Ask whether the firm is accepting your case or only gathering information, and keep the answer with your product and dental records.
The review is free and private. Asking for it doesn’t commit you to anything.
Register your interestChecked against 10 primary sources by People's Justice editors · Updated
How we make moneyPeople's Justice research team · Updated Oct 4, 2026